全文获取类型
收费全文 | 1363493篇 |
免费 | 95790篇 |
国内免费 | 2984篇 |
专业分类
耳鼻咽喉 | 20162篇 |
儿科学 | 40890篇 |
妇产科学 | 38996篇 |
基础医学 | 190796篇 |
口腔科学 | 40255篇 |
临床医学 | 115357篇 |
内科学 | 268349篇 |
皮肤病学 | 30396篇 |
神经病学 | 109108篇 |
特种医学 | 54831篇 |
外国民族医学 | 435篇 |
外科学 | 212852篇 |
综合类 | 31288篇 |
现状与发展 | 6篇 |
一般理论 | 507篇 |
预防医学 | 94020篇 |
眼科学 | 31713篇 |
药学 | 101713篇 |
4篇 | |
中国医学 | 3009篇 |
肿瘤学 | 77580篇 |
出版年
2018年 | 12482篇 |
2016年 | 11163篇 |
2015年 | 12529篇 |
2014年 | 17636篇 |
2013年 | 26486篇 |
2012年 | 34975篇 |
2011年 | 36886篇 |
2010年 | 21932篇 |
2009年 | 21199篇 |
2008年 | 35429篇 |
2007年 | 38583篇 |
2006年 | 39103篇 |
2005年 | 37811篇 |
2004年 | 36728篇 |
2003年 | 35643篇 |
2002年 | 35126篇 |
2001年 | 63884篇 |
2000年 | 65533篇 |
1999年 | 55650篇 |
1998年 | 14970篇 |
1997年 | 13710篇 |
1996年 | 13146篇 |
1995年 | 12433篇 |
1994年 | 11643篇 |
1992年 | 42913篇 |
1991年 | 41447篇 |
1990年 | 40714篇 |
1989年 | 39670篇 |
1988年 | 37070篇 |
1987年 | 36512篇 |
1986年 | 35003篇 |
1985年 | 33211篇 |
1984年 | 24961篇 |
1983年 | 21168篇 |
1982年 | 12781篇 |
1981年 | 11677篇 |
1979年 | 23982篇 |
1978年 | 17130篇 |
1977年 | 14888篇 |
1976年 | 13418篇 |
1975年 | 15291篇 |
1974年 | 18112篇 |
1973年 | 17586篇 |
1972年 | 16833篇 |
1971年 | 15747篇 |
1970年 | 14925篇 |
1969年 | 14363篇 |
1968年 | 13482篇 |
1967年 | 12026篇 |
1966年 | 11274篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
Michael L. Goodman Miriam S. Mutambudzi Stanley Gitari Philip H. Keiser Sarah E. Seidel 《Vulnerable children and youth studies》2016,11(4):366-378
There are an estimated 56 million orphans and vulnerable children across sub-Saharan Africa. Communities typically care for orphan children through informal caring arrangements – either within or outside of kinship networks. Within Kenya, an estimated 250,000 children live on the streets. There is less research related to fostering attitudes of this special population than orphans and vulnerable children generally. Important research over the past decade has illuminated multiple ways in which children are made more vulnerable because of HIV, including parental death and street-migration from HIV-affected households. As HIV transitions from a terminal illness to a chronic, manageable one, research is also required to establish how parents living with HIV can be an asset to children. In this study, we assess whether mothers living with HIV were very willing to foster biologically-related children, and street-involved children, how these fostering attitudes differed from mothers not living with HIV, and whether differences in fostering attitudes by reported HIV status were mediated by social support, family functioning and general self-rated health. Approximately 40% of mothers living with HIV were very willing to provide long-term foster care to biologically-related or street-involved children. This was less than the percentage of mothers not living with HIV, who were very willing to foster biologically-related children (61%) or street-involved children (58%). Significant portions of these differences were explained by social support, family functioning and general self-rated health. Multi-sectoral approaches are suggested by these findings in order to improve the child-fostering capacity of mothers living with HIV. Improving social support, family functioning and general self-rated health among HIV-infected mothers may not only provide protective benefits for the mothers and their children, but also expand the community’s capacity to care for orphan and vulnerable children. 相似文献
43.
Andrea Stracciolini Jennifer Luz Gregory Walker Nicholas M. Edwards Avery D. Faigenbaum Gregory D. Myer 《The Physician and sportsmedicine》2020,48(2):199-207
ABSTRACT
Objective
To investigate primary care physician clinical practice patterns, barriers, and education surrounding pediatric physical activity (PA), and to compare practice patterns by discipline. 相似文献44.
45.
46.
47.
48.
49.
David M. Presby Michael C. Rudolph Vanessa D. Sherk Matthew R. Jackman Rebecca M. Foright Kenneth L. Jones Julie A. Houck Ginger C. Johnson Janine A. Higgins P. Darrell Neufer Robert H. Eckel Paul S. MacLean 《Diabetes》2021,70(4):867
Moderate weight loss improves numerous risk factors for cardiometabolic disease; however, long-term weight loss maintenance (WLM) is often thwarted by metabolic adaptations that suppress energy expenditure and facilitate weight regain. Skeletal muscle has a prominent role in energy homeostasis; therefore, we investigated the effect of WLM and weight regain on skeletal muscle in rodents. In skeletal muscle of obesity-prone rats, WLM reduced fat oxidative capacity and downregulated genes involved in fat metabolism. Interestingly, even after weight was regained, genes involved in fat metabolism were also reduced. We then subjected mice with skeletal muscle lipoprotein lipase overexpression (mCK-hLPL), which augments fat metabolism, to WLM and weight regain and found that mCK-hLPL attenuates weight regain by potentiating energy expenditure. Irrespective of genotype, weight regain suppressed dietary fat oxidation and downregulated genes involved in fat metabolism in skeletal muscle. However, mCK-hLPL mice oxidized more fat throughout weight regain and had greater expression of genes involved in fat metabolism and lower expression of genes involved in carbohydrate metabolism during WLM and regain. In summary, these results suggest that skeletal muscle fat oxidation is reduced during WLM and regain, and therapies that improve skeletal muscle fat metabolism may attenuate rapid weight regain. 相似文献
50.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献